Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

Figure 2

Calibration curve of Nateglinide in 0.01 N HCl with 0.5% w/v SLS.